Profiling protease cleavage patterns in plasma for pancreatic cancer detection

Area of Science:

• Biochemistry
• Proteomics
• Cancer Diagnostics

Background:

• Proteases are valuable biomarkers for early cancer detection due to their enzymatic activity.
• Developing specific protease tests is challenging due to proteome complexity.
• Current methods struggle with sensitivity and selectivity for specific protease biomarkers.

Purpose of the Study:

• To develop a novel strategy for pancreatic cancer early detection using total protease activity.
• To identify specific FRET substrates capable of distinguishing pancreatic ductal adenocarcinoma (PDAC) from other conditions.
• To validate the efficacy of selected substrates in a larger patient cohort.

Main Methods:

• Utilized an array of 360 Förster Resonance Energy Transfer (FRET) substrates to screen plasma samples.
• Employed a two-stage approach: initial screening of 360 substrates in a small cohort, followed by validation with selected substrates in a larger cohort.
• Analyzed plasma samples from screen negatives, pancreatitis patients, and PDAC patients.

Main Results:

• Identified a statistically significant increase in total protease activity in PDAC samples compared to controls and pancreatitis samples.
• The selected FRET substrates demonstrated high diagnostic performance, achieving an Area Under the Curve (AUC) of 0.8 for PDAC detection.
• This proof-of-concept study successfully established a novel strategy for PDAC detection.

Conclusions:

• Measuring total protease activity via FRET substrate arrays offers a promising new avenue for pancreatic cancer early detection.
• This approach overcomes limitations of targeting specific protease biomarkers, providing a more robust diagnostic method.
• The identified FRET substrates represent a novel tool for detecting PDAC and potentially other cancers.